SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-077790
Filing Date
2022-12-06
Accepted
2022-12-06 09:45:28
Documents
12
Period of Report
2022-12-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea169702-8k_aikidophar.htm   iXBRL 8-K 33862
  Complete submission text file 0001213900-22-077790.txt   207564

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE aiki-20221205.xsd EX-101.SCH 3239
3 XBRL LABEL FILE aiki-20221205_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE aiki-20221205_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT ea169702-8k_aikidophar_htm.xml XML 3602
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 221446841
SIC: 2834 Pharmaceutical Preparations